• Accelerating TB vaccine Research & Development through partnership
    • TBVI TBVI TBVI
    • Home
    • News
    • Projects
      • Projects
      • For researchers and vaccine developers
        • Partners pages
        • Access to services
      • MTBVAC in Newborns
        • Coordinator and partners
        • Communication tools
        • News and Publications
      • MTBVACN3
        • Work packages
        • Governance
        • The consortium and its partners
        • Publications and news
        • Acknowledgement
      • TBVAC-HORIZON
      • TBVAC2020
        • Word from the chair
        • TBVAC2020 project overview and achievements
        • TBVAC2020 project members
        • TBVAC2020 scientific publications
        • TBVAC2020 other publications
          • TBVI R&D priorities and funding opportunities
          • TBVI service provision and funding opportunities
          • Why invest in TBVI
      • ITHEMYC
        • Project overview
        • Consortium partners
        • News and Publications
      • Partners
    • About us
      • TBVI at a glance
      • Mission
      • Organisation
        • Governance Board
        • Advisory Committee
        • Steering Committee
        • Operational Office
        • Product and Clinical Development Team
      • TBVI consortium
      • Key achievements and impact
      • Financials
      • Policies
    • What we do
      • Pipeline of vaccines
      • Research & Development
      • Services
    • How we work
      • Business model
      • Partnership
    • Contact us:

    Archives

    Monthly Archive for: "April, 2022"
    Home / 2022 / April
      1
    By Silvia
    In Uncategorized Posted April 7, 2022

    2nd Global Online Consultation to Develop Global Plan to End TB 2023-2030

    Stop TB Partnership Announcement – 01 April 2022 Launched 2nd Global Online Consultation to Develop Global Plan to End TB 2023 – 2030  

    Read More
    Load More
    Menu
    • Home
    • News
    • Projects
    • About us
    • What we do
    • How we work
    • Partners
    • Pipeline of vaccines
    TuBerculosis Vaccine Initiative (TBVI)

    Runderweg 6
    8219 PK Lelystad
    The Netherlands
    Email: info@tbvi.eu
    Phone: 0031 (0)6 1099 5196

    © 2015 TuBerculosis Vaccine Initiative (TBVI) | ALL RIGHTS RESERVED | Disclaimer | Sitemap | Door Internetbureau Redkiwi

    Start typing and press Enter to search

    Cookies

    This website uses cookies that help the website function

    OK No